Business · 15/04/1994Updated: 10/15/2026 · 1 min read
Determination of Regulatory Review Period for Purposes of Patent Extension; MycobutinSUPTM
Summary
The Food and Drug Administration (FDA) has determined the regulatory review period for Mycobutin TM and is publishing this notice as required by law due to an application for patent extension.
Original source language: Federal Register — Health and Human ServicesOpen original release →